Hepatobiliary & Pancreatic Diseases International2024，Vol.23Issue(3)：P.326-330,5.DOI:10.1016/j.hbpd.2023.10.004
Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment
Feng Zhu 1Yi-Ming Wang 2Ming Ni 2Yuan Liang 2Jie-Hui Huang 3Xue-Hao Wang 2Feng Cheng 2Ling Lu4
作者信息
- 1. Hepatobiliary Center,The First Affiliated Hospital of Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,NHC Key Laboratory of Liver Transplantation,Research Unit of Liver Transplantation and Transplant Immunology,Chinese Academy of Medical Sciences,Nanjing 210000,China Department of Respiratory and Critical Care Medicine,Wuxi Fifth People’s Hospital,Wuxi 214000,China
- 2. Hepatobiliary Center,The First Affiliated Hospital of Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,NHC Key Laboratory of Liver Transplantation,Research Unit of Liver Transplantation and Transplant Immunology,Chinese Academy of Medical Sciences,Nanjing 210000,China
- 3. Department of Respiratory and Critical Care Medicine,Wuxi Fifth People’s Hospital,Wuxi 214000,China
- 4. Hepatobiliary Center,The First Affiliated Hospital of Nanjing Medical University,Key Laboratory of Liver Transplantation,Chinese Academy of Medical Sciences,NHC Key Laboratory of Liver Transplantation,Research Unit of Liver Transplantation and Transplant Immunology,Chinese Academy of Medical Sciences,Nanjing 210000,China Jiangsu Key Laboratory of Cancer Biomarkers,Prevention and Treatment,Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing Medical University,Nanjing 210000,China
- 折叠
摘要
关键词
dosage/treatment/antagonist分类
医药卫生引用本文复制引用
Feng Zhu,Yi-Ming Wang,Ming Ni,Yuan Liang,Jie-Hui Huang,Xue-Hao Wang,Feng Cheng,Ling Lu..Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment[J].Hepatobiliary & Pancreatic Diseases International,2024,23(3):P.326-330,5.基金项目
The study was supported by grants from the National Natural Science Foundation of China(81871259,81971495,82070675,81530048,82200731 and 81570562) （81871259,81971495,82070675,81530048,82200731 and 81570562）
the Foundation of Jiangsu Collaborative Innovation Center of Biomedical Functional Materials,and the Priority Academic Program Development of Jiangsu Higher Education Institutions. （）
